Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Dubava, M. Tirzite, I. Stukena, A. Krams, A. Lejnieks (Riga, Latvia). Potential role of total antioxidant status ratio in differential diagnosis of pleural effusion. Eur Respir J 2013; 42: Suppl. 57, 3097

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Association of biochemical determinants and fibrinous formation in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 The Role of PET-CT in differential diagnosis of malignant-paramalignant pleural effusion Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Relationship between amount of pleural effusion and etiology Source: Eur Respir J 2006; 28: Suppl. 50, 579s Year: 2006 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Investigating unilateral pleural effusions: the role of cytology Source: Eur Respir J, 52 (5) 1801254; 10.1183/13993003.01254-2018 Year: 2018 Investigating unilateral pleural effusions: the role of cytology. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Determination of the extent of pleural effusion: factors influencing clinical assessment Source: Eur Respir J 2004; 24: Suppl. 48, 538s Year: 2004 Diagnostic role of biology markers in 75 patients with pleural effusion Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 The role of neopterine level in the differential diagnosis of tuberculoid pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 507s Year: 2006 Comparison of multiple serum and pleural fluid biomarkers for the diagnosis of Malignant Pleural Mesothelioma Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Importance of complement C3-C4 levels on differential diagnosis of pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 688s Year: 2005 A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions Source: Eur Respir J 2013; 41: 18-24 Year: 2013 Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Role of gene Xpert in diagnosis of tuberculous pleural effusion: Comparison with pleural biopsy Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014